TRT and Flying: Everything You Need to Know Before You Travel
How to fly with prescribed testosterone: TSA screening for vials, gel, and syringes; international controlled-drug checks; product storage; and a safe missed-dose plan.
TRT and Hair Loss: What the Evidence Actually Shows
Does testosterone replacement therapy cause hair loss? Learn the DHT mechanism, who is genuinely at risk, how to monitor for shedding on TRT, and which treatments can protect hair without stopping therapy.
TRT and Statins: Interactions, Lipid Effects, and What to Monitor
A guide covering how testosterone replacement therapy interacts with statins, how each drug affects your lipid panel, what labs to monitor, and how to manage TRT alongside supplements and lifestyle factors.
TRT for Low Libido: Does Testosterone Therapy Actually Restore Sex Drive?
Learn how testosterone replacement therapy (TRT) affects libido, who qualifies, what doses are used, and what the clinical evidence says about restoring sex drive in men with hypogonadism.
TRT for Obesity and Metabolic Syndrome: What Men Need to Know
Testosterone replacement therapy can improve insulin sensitivity, reduce visceral fat, and restore libido in men with hypogonadism and metabolic syndrome. Learn the evidence, doses, and protocols.
TRT Prior Authorization: What It Means, What Insurers Require, and How to Cut Your Costs
A clinical guide to TRT prior authorization requirements, insurance coverage rules, Medicare policies, and real monthly cost breakdowns for testosterone replacement therapy in 2025.
TRT With Creatine and Protein: How to Stack Supplements Safely on Testosterone Replacement Therapy
Creatine cypionate isn't a single product. Creatine monohydrate is the 3-5 g/day supplement; testosterone cypionate is injectable TRT. They don't interact.
TRT With Peptides: Protocols, Benefits, and Safety by Age Group
A guide to combining testosterone replacement therapy with peptides. Covers GH secretagogues, BPC-157, TB-500, and age-specific protocols for men over 50, men over 65, younger men, and bodybuilders.
How to Safely Get TRT Cream Online: A Guide
A guide to getting testosterone cream (transdermal TRT) safely through a legitimate online telehealth provider, covering who qualifies, how to read labs, what to expect, and red flags to avoid.
Why Perimenopause Feels Like a Rollercoaster: Understanding Neurotransmitter Shifts After 40
Perimenopause triggers dramatic swings in estrogen and progesterone that destabilize serotonin, dopamine, GABA, and norepinephrine. Learn exactly why your brain chemistry changes after 40 and what clinical options can help.
How to Increase Testosterone Naturally: A Practical Guide for Men
A guide covering diet, exercise, sleep, stress, and lifestyle strategies that have demonstrated measurable effects on testosterone levels in peer-reviewed trials.
Metformin for NAFLD / MASLD: Evidence, Dosing, and Clinical Use
A guide to using metformin in NAFLD / MASLD patients: what the trials actually show, how to dose it, who benefits most, and where newer agents fit in.
Metformin Dosage for Type 2 Diabetes: 500mg to 2,000mg
Standard metformin dosing starts at 500mg with meals, up to 2,000mg daily max. Lowers HbA1c 1.0-1.5 points; backed by UKPDS 34 trial data.
Metformin in Hepatic Impairment: Dosing by Child-Pugh Class
Metformin is avoided in severe liver disease (Child-Pugh C or AST/ALT over 3x ULN); mild-to-moderate cases may use cautious low-dose therapy.
Metformin Real-World Evidence: What Registries and RWE Studies Actually Show
A deep dive into metformin real-world evidence from major registries and RWE studies, covering mechanism, cardiovascular outcomes, cancer signals, and how registry data compares to RCT findings.
Metformin in Special Populations: Transplant, HIV, Elderly, Pregnancy, and More
A clinician-level guide to metformin dosing, safety, and pharmacology in transplant recipients, people living with HIV, older adults, pregnant patients, and other special populations. Evidence-based, PubMed-cited.
Metformin Appetite & Cravings Changes: What the Evidence Actually Shows
A clinician-level review of how metformin affects appetite, cravings, and food intake. Covers proposed mechanisms, clinical trial data, practical dosing context, and what patients can realistically expect.
Metformin Cancer Risk Signal Review: What the Evidence Actually Shows
A clinician-level review of metformin's cancer risk signals, covering proposed mechanisms, key trials, confounding factors, and current guideline positions for patients with type 2 diabetes or prediabetes.
Metformin Compounded vs. Branded: A Clinical Comparison
A comparison of compounded and branded metformin, covering bioequivalence, cost, formulation differences, safety, and how to choose the right option for type 2 diabetes or prediabetes management.
Metformin Mental Health and Mood Impact
An evidence-based look at how metformin affects mental health and mood, covering depression, cognitive function, anxiety, B12 depletion, and clinical management guidance.
Metformin Microdosing Protocols: What the Evidence Actually Shows
A clinical review of metformin microdosing protocols for type 2 diabetes, prediabetes, longevity, and off-label use. Covers dosing thresholds, tolerability data, titration schedules, and what current guidelines do and do not support.
Metformin After Bariatric Surgery: What Clinicians and Patients Need to Know
A clinical deep-dive into metformin use after bariatric surgery, covering pharmacokinetics, B12 depletion, RYGB vs sleeve gastrectomy differences, dosing, and when to stop or restart.
Metformin Restarting After Acute Illness: A Clinical Guide
When and how to safely restart metformin after acute illness, hospitalization, or surgery. Evidence-based guidance covering lactic acidosis risk, renal thresholds, contrast dye rules, and step-by-step restart protocols.
Metformin Rebound Effects When Stopping: What the Evidence Actually Shows
Stopping metformin can cause blood glucose to rise sharply within days. This guide covers the clinical evidence on rebound hyperglycemia, the mechanisms behind it, who is most at risk, and how to taper or transition safely.
Metformin Seasonal Use Considerations: A Clinical Guide
How temperature extremes, seasonal illness, hydration shifts, and activity changes affect metformin dosing, safety, and efficacy across all four seasons. MD/PharmD-level guidance with primary-literature citations.
Metformin Sleep Architecture Impact: What the Evidence Actually Shows
A clinician-level review of how metformin affects sleep architecture, slow-wave sleep, REM duration, and circadian signaling, with primary-literature citations and dosing context.
Metformin Travel & Timezone-Shift Protocols
How metformin dosing, GI tolerability, contrast imaging, and altitude exposure interact during travel, with a clinician-discussion and monitoring framework for patients and prescribers.
Methimazole (Tapazole) Hair and Skin Changes: What Patients and Clinicians Need to Know
A full clinical review of methimazole-induced and hyperthyroidism-related hair and skin changes, including alopecia, urticaria, and vasculitis, with primary-literature citations and management guidance.
MK-677 (Ibutamoren) Overdose and Accidental Excess Dose: Clinical Management Guide
What happens when you take too much MK-677 (ibutamoren)? A guide covering mechanism, overdose signs, dose thresholds, and clinical management with primary-source citations.
MK-677 (Ibutamoren) Dosing in Renal Impairment
A clinical deep-dive into MK-677 (ibutamoren) dosing adjustments for patients with renal impairment, covering pharmacokinetics, GH/IGF-1 physiology, trial data, and prescriber guidance.
MK-677 (Ibutamoren) Safety Signals & FDA Actions
A deep dive into MK-677 (ibutamoren) safety signals, FDA enforcement actions, mechanism of action, and what the clinical trial record actually shows about risks at every dose studied.
MK-677 (Ibutamoren) Appetite & Cravings Changes: What the Clinical Evidence Actually Shows
A deep dive into how MK-677 (ibutamoren) affects appetite and food cravings, covering ghrelin mechanisms, clinical trial data, onset timing, and how to manage hunger side effects safely.
MK-677 (Ibutamoren) Autoimmune Disease Considerations
A guide to MK-677 (ibutamoren) in patients with autoimmune conditions. Covers GH/IGF-1 immune modulation, clinical trial data, risks, and practical management.
MK-677 (Ibutamoren) Cancer Risk Signal Review
A physician-level review of MK-677 (ibutamoren) cancer risk signals, covering IGF-1 biology, clinical trial data, preclinical findings, and practical safety guidance for patients and clinicians.
MK-677 (Ibutamoren) Cardiovascular Impact: Long-Term Clinical Review
A deep-dive into MK-677 (ibutamoren) cardiovascular effects, covering fluid retention, blood pressure, insulin resistance, and what the longest human trials actually found.
MK-677 (Ibutamoren) Cognitive Function Impact: What the Clinical Evidence Actually Shows
A analysis of MK-677 (ibutamoren) and its effects on cognition, memory, and brain health, covering RCT data, GH/IGF-1 mechanisms, sleep quality research, and safety considerations for anyone evaluating this secretagogue.
MK-677 (Ibutamoren) Evidence Base Graded by GRADE
A GRADE-level appraisal of every published MK-677 (ibutamoren) clinical trial: GH/IGF-1 endpoints, body composition, bone density, sleep, cognition, and safety, prepared for editorial and medical review.
MK-677 (Ibutamoren) Metabolism and Energy Expenditure: What the Clinical Data Actually Shows
A analysis of how MK-677 (ibutamoren) affects metabolic rate, energy expenditure, GH/IGF-1 signaling, body composition, and insulin sensitivity, with citations from primary clinical trials.
MK-677 (Ibutamoren) Microdosing Protocols: What the Evidence Actually Shows
A breakdown of MK-677 (ibutamoren) microdosing protocols, clinical trial data, GH/IGF-1 pharmacokinetics, and safety considerations for anyone researching this investigational GH secretagogue.
MK-677 (Ibutamoren) Renal Protection or Renal Risk: What the Evidence Actually Shows
A analysis of MK-677 (ibutamoren) and kidney function: does this GH secretagogue protect the renal system, pose risks, or neither? Primary-literature citations throughout.
MK-677 (Ibutamoren) Seasonal Use Considerations
A guide to how season, light exposure, temperature, and circadian biology interact with MK-677 (ibutamoren) dosing, timing, and expected outcomes throughout the year.
MK-677 (Ibutamoren) Sexual Function Impact: What the Clinical Evidence Actually Shows
A analysis of how MK-677 (ibutamoren) affects sexual function, libido, and hormone levels, including clinical trial data, known mechanisms, and risks.
MK-677 (Ibutamoren) Sleep Architecture Impact: What the Clinical Evidence Actually Shows
A analysis of how MK-677 (ibutamoren) affects sleep architecture, REM and slow-wave sleep duration, GH pulse timing, and what the clinical trial data mean for patients and clinicians.
MOTS-c Cardiovascular Impact: What the Long-Term Evidence Shows
A deep dive into how the mitochondrial peptide MOTS-c affects cardiovascular risk, lipid metabolism, vascular function, and cardiac remodeling, covering the latest preclinical and emerging clinical data.
MOTS-c Evidence Base Graded by GRADE: What the Data Actually Show
A GRADE-graded review of every MOTS-c clinical and preclinical study available in 2025, covering insulin sensitization, metabolic health, aging biology, and what is still missing before human clinical guidance can be issued.
MOTS-c Hair and Skin Changes: What the Evidence Actually Shows
A clinician-level review of how MOTS-c, the mitochondrial-derived peptide, may affect hair follicle cycling, dermal collagen, sebaceous function, and skin aging, with primary-literature citations, real doses, and a clear framework for managing patient expectations.
MOTS-c Liver Function Impact: What the Research Shows
A clinician-level review of how MOTS-c, the mitochondrial-derived peptide, affects hepatic insulin signaling, lipid metabolism, NAFLD pathology, and liver enzyme markers. Includes primary-literature citations and a clinical decision framework.
MOTS-c Microdosing Protocols: What the Evidence Actually Shows
A clinician-level review of MOTS-c microdosing protocols, mechanism of action, current human trial data, and dosing frameworks used in research settings. prepared by the HealthRX.com Editorial Team.
MOTS-c Muscle Preservation Strategies: What the Mitochondrial Peptide Research Shows
A clinical deep-dive into MOTS-c mitochondrial peptide and its muscle preservation mechanisms, covering trial data, dosing frameworks, and practical protocols prepared by the HealthRX.com Editorial Team.
MOTS-c Pre-Surgery Hold Window: What Patients and Clinicians Need to Know
A clinical guide to the MOTS-c pre-surgery hold window, covering pharmacology, perioperative risk rationale, recommended discontinuation timing, and restart criteria.
MOTS-c Sleep Architecture Impact: What the Evidence Actually Shows
A clinician-level review of how the mitochondrial peptide MOTS-c may influence sleep architecture, circadian signaling, and metabolic recovery during sleep, with primary-literature citations and a practical clinical framework.
Mounjaro (Tirzepatide) Adolescent (12 to 17) Monitoring: The Complete Clinical Guide
A guide to monitoring tirzepatide (Mounjaro) in adolescents aged 12 to 17, covering labs, growth, mental health, dosing schedules, and safety checkpoints.
Mounjaro Bone Health and Density Impact: What the Evidence Shows
A deep dive into how tirzepatide (Mounjaro) affects bone mineral density, fracture risk, and bone turnover markers, with primary-literature citations and practical guidance.
Mounjaro Mental Health and Mood Impact: What the Evidence Actually Shows
A clinician-level review of tirzepatide's effects on mood, depression, anxiety, and cognitive function, including trial data, proposed mechanisms, and what to watch for during treatment.
Mounjaro Muscle Preservation Strategies: A Clinical Guide
Evidence-based strategies to preserve lean muscle mass while losing weight on Mounjaro (tirzepatide), including protein targets, resistance training protocols, and lab monitoring guidance prepared by the HealthRX.com Editorial Team.
Mounjaro Pre-Surgery Hold Window: How Long to Stop Tirzepatide Before an Operation
Evidence-based guidance on when to stop Mounjaro (tirzepatide) before surgery, why gastroparesis risk drives anesthesia concerns, and how to coordinate your hold with your surgical team.
NMN & NR Food and Supplement Interactions: What You Need to Know
A practical guide to NMN and NR with meals, alcohol, other supplements, warfarin, diabetes medicines, and cancer treatment, with cited human studies.
NMN/NR (Nicotinamide Mononucleotide/Riboside) Geriatric (65+) Monitoring: A Clinical Guide
A guide to monitoring NMN and NR supplementation in adults 65 and older, covering NAD+ levels, renal function, drug interactions, metabolic markers, and safety checkpoints.
NMN and NR Safety for Adults Ages 50 to 64: What the Clinical Evidence Actually Shows
A guide to the safety of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) supplements for adults aged 50 to 64, covering trial data, drug interactions, dosing, and red flags.
NMN/NR (Nicotinamide Mononucleotide/Riboside) Young Adult (18 to 29) Monitoring: What to Track and Why
A guide to monitoring NMN and NR supplementation in adults aged 18 to 29, covering baseline labs, safety signals, fertility considerations, and how to interpret changes in NAD+ biomarkers.